Literature DB >> 6113480

The filter cigarette and coronary heart disease: the Framingham study.

W P Castelli, R J Garrison, T R Dawber, P M McNamara, M Feinleib, W B Kannel.   

Abstract

Long-term follow-up of the Framingham cohort for coronary heart disease (CHD) end-points has made it possible to test the hypothesis that those who smoke filter cigarettes are less likely to get clinical manifestations of CHD than those who smoke non-filter cigarettes. Men were classified at the 7th biennial examination (1963--64) according to whether they smoked filter or non-filter cigarettes. 58% of the cigarette-smoking men under age 55 at this examination smoked filter cigarettes. These men had slightly lower prior smoking exposure than smokers of non-filter cigarettes. Despite what seemed to be a favourable cigarette-smoking history, the filter-cigarette smokers did not have lower CHD incidence rates than non-filter smokers. This finding was unchanged even after multivariate logistic regression analysis to adjust for the slight differences in age, systolic blood pressure, and serum cholesterol between the two groups.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113480     DOI: 10.1016/s0140-6736(81)90297-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

Review 1.  Risk factors for cardiovascular disease and hormone therapy in women.

Authors:  P Collins
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

2.  Smoking, smoking cessation, and risk of cardiovascular disease.

Authors:  Peter W F Wilson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

3.  Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study).

Authors:  Noriaki Nakaya; Kyoichi Mizuno; Yasuo Ohashi; Tamio Teramoto; Shinji Yokoyama; Katsumi Hirahara; Masahiro Mizutani; Haruo Nakamura
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

Review 4.  The effects of acrolein on the thioredoxin system: implications for redox-sensitive signaling.

Authors:  Charles R Myers; Judith M Myers; Timothy D Kufahl; Rachel Forbes; Adam Szadkowski
Journal:  Mol Nutr Food Res       Date:  2011-08-03       Impact factor: 5.914

5.  Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators.

Authors:  S Parish; R Collins; R Peto; L Youngman; J Barton; K Jayne; R Clarke; P Appleby; V Lyon; S Cederholm-Williams
Journal:  BMJ       Date:  1995-08-19

Review 6.  The search for safer cigarettes.

Authors:  T Higenbottam
Journal:  BMJ       Date:  1989-10-21

7.  Validity of smokers' information about present and past cigarette brands--implications for studies of the effects of falling tar yields of cigarettes on health.

Authors:  H Peach; D Shah; R W Morris
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

8.  Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts.

Authors:  J L Tang; J K Morris; N J Wald; D Hole; M Shipley; H Tunstall-Pedoe
Journal:  BMJ       Date:  1995-12-09

9.  Tar yield of cigarettes and risk of acute myocardial infarction. GISSI-EFRIM Investigators.

Authors:  E Negri; M G Franzosi; C La Vecchia; L Santoro; A Nobili; G Tognoni
Journal:  BMJ       Date:  1993-06-12

10.  Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smoked.

Authors:  M R Alderson; P N Lee; R Wang
Journal:  J Epidemiol Community Health       Date:  1985-12       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.